COVID-19
AMR is a world-wide leader in the fight against COVID-19.
AMR is committed to advancing COVID-19 research and is actively monitoring the situation as it continues to develop. AMR locations across the country have remained open proactively adding top industry professionals to our team while securing additional office space to ensure we are best positioned to be deliver industry-leading COVID Research.
AMR continues to provide the industry and sponsors with rapid study start times and was involved in a number of the first Operation Warp Speed Trials. AMR remains committed to COVID research and is conducting a number of trials both on vaccines and potential treatments at many of its locations nationwide.
Medical professionals who are interested in getting involved in COVID research can email us at covid19@amrllc.com. Individuals who are interested in volunteering for a COVID vaccine or treatment trial should click the PARTICIPATE link above or continue scrolling down the page to see the open trials at our locations.
DO YOUR PART
Find a Study Near You.
COVID-19 Clinical Research Studies
AMR locations nationwide are currently conducting or will soon be conducting several COVID-19 investigational clinical research studies. As with all studies, some exclusions will apply. However, we will have multiple studies needing participants from all walks of life. Compensation will be available for time and travel.
At this time, there is no proven prevention vaccine so this would offer potential coverage and an opportunity to help advance science in developing a proven vaccine.
El Dorado: 316-600-5127 eldorado@amrllc.com
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
Fort Myers: 239-936-4421 fortmyers@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Kansas City: 816-943-0770 kansascity@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Knoxville: 865-305-3784 knoxville@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Las Vegas: 702-545-6840 lasvegas@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Lexington: 859-264-8999 lexington@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Miami: 305-445-5637 miami@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Treatment Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine (ages 18+ and 5-17) (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
Mobile: 251-414-1984 mobile@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
Newton: 316-283-0828 newton@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Tempe: 602-759-7559 tempe@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
Wichita – East: 316-689-6609 wichita-east@amrllc.com
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Refer-A-Friend Program
“Refer-A-Friend” at many of our locations to earn extra cash. If a friend or family member is deemed eligible to participate (randomizes) in one of our clinical research studies, you will receive $50.00!*There is no limit on the number of referrals you can provide. This is intended for your family and friends and you may not advertise or make any general solicitations for individuals to participate in a study. Compensation is mailed out after your referralhas qualified for (randomized into) the study.For questions about the Refer-A-Friend program, contact the AMR location nearest you.
